[
  {
    "ts": null,
    "headline": "Should You Continue to Retain Insulet Stock in Your Portfolio Now?",
    "summary": "PODD stock stays on investors' radar owing to its solid progress with Omnipod 5 and robust potential in the diabetes market.",
    "url": "https://finnhub.io/api/news?id=a55073e277db6ebccf548b237fcc88057ccc6d5cbcdaae8618ece6f7db33d4c2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733746920,
      "headline": "Should You Continue to Retain Insulet Stock in Your Portfolio Now?",
      "id": 131870422,
      "image": "https://media.zenfs.com/en/zacks.com/41b7bdd28f63138df08f17b665d3589a",
      "related": "PODD",
      "source": "Yahoo",
      "summary": "PODD stock stays on investors' radar owing to its solid progress with Omnipod 5 and robust potential in the diabetes market.",
      "url": "https://finnhub.io/api/news?id=a55073e277db6ebccf548b237fcc88057ccc6d5cbcdaae8618ece6f7db33d4c2"
    }
  }
]